SCHEMBL14347918

SCHEMBL14347918

Cc1ccc(C2(C(=O)CN3CCOCC3)CCC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ CYP3A4 P08684 3/20 0.48
▸ CYP2C19 P33261 3/20 0.48
▸ TSHR P16473 1/20 0.48
▸ ALDH1A1 P00352 5/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ POLB P06746 2/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ PRCP P42785 1/20 0.44
▸ TMEM97 Q5BJF2 1/20 0.44
▸ SIGMAR1 Q99720 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14347919 0.97 MEN1 (0.48) MEN1KMT2ACYP3A4CYP2C19TSHR
SCHEMBL14347908 0.94 MEN1 (0.50) MEN1KMT2ACYP3A4CYP2C19TSHR
SCHEMBL8351554 0.89 USP2 (0.45) MEN1KMT2ATSHRALDH1A1POLB
SCHEMBL8353497 0.86 USP2 (0.45) MEN1KMT2AMAPK1POLBRAB9A
SCHEMBL8351187 0.84 USP2 (0.46) MEN1KMT2ATSHRALDH1A1POLB
SCHEMBL19242698 0.83 SMN1; SMN2 (0.62) MEN1KMT2ACYP3A4CYP2C19TSHR
SCHEMBL8351183 0.83 HPGD (0.46) MEN1KMT2ATSHRALDH1A1POLB
SCHEMBL4211581 0.73 SMN1; SMN2 (0.71) MEN1KMT2APOLBSMN1; SMN2
SCHEMBL16523027 0.73 HSD11B1 (0.62) ALDH1A1SIGMAR1SMN1; SMN2NPC1
SCHEMBL19242799 0.73 KMT2A (0.62) MEN1KMT2ACYP3A4CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 — — US disclosed
Send feedback